A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel - A novel potential intravaginal virucide

被引:45
作者
Stafford, MK
Cain, D
Rosenstein, I
Fontaine, EA
McClure, M
Flanagan, AM
Smith, JR
TaylorRobinson, D
Weber, J
Kitchen, VS
机构
[1] ST MARYS HOSP,SCH MED,CLIN TRIALS CTR,JEFFERISS RES TRUST LABS,LONDON W2 1NY,ENGLAND
[2] ST MARYS HOSP,SCH MED,MRC,SEXUALLY TRANSMITTED DIS RES GRP,LONDON W2 1NY,ENGLAND
[3] ST MARYS HOSP,SCH MED,DEPT HISTOPATHOL,LONDON W2 1NY,ENGLAND
[4] CHELSEA & WESTMINSTER HOSP,DEPT OBSTET & GYNAECOL,LONDON,ENGLAND
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1997年 / 14卷 / 03期
关键词
dextrin sulphate; intravaginal virucide;
D O I
10.1097/00042560-199703010-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A double-blind, placebo-controlled study was designed to evaluate the safety and tolerability of intravaginal dextrin sulphate (D2S) gel to assess its preliminary suitability as a potential vaginal virucide. Tolerability was assessed by questionnaire and patient interview. Colposcopy with vaginal biopsy was performed to assess the macroscopic and microscopic evidence of inflammation. The potential impact of the gel on normal vaginal flora was examined by quantitative lactobacilli culture with assessment of the ratio of peroxide to nonperoxide producing organisms. Colposcopy revealed mild erythema in five of 24 subjects receiving active gel and in none of the 12 placebo recipients, but histology in all subjects revealed no evidence of inflammation. No impact on vaginal lactobacilli was found. We conclude that D2S gel is safe and well tolerated intravaginally at the dosing schedule used in this study.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 21 条
[1]   HIV REPLICATION IN CD4-NEGATIVE CELL-LINES - EFFECT OF CLONING, CD4 EXPRESSION AND INHIBITION BY DEXTRIN SULFATE [J].
BEDDOWS, S ;
BIENIASZ, P ;
SHAUNAK, S ;
WEBER, J .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1993, 4 (03) :173-177
[2]   CHALLENGES FOR THE DEVELOPMENT OF FEMALE-CONTROLLED VAGINAL MICROBICIDES [J].
ELIAS, CJ ;
HEISE, LL .
AIDS, 1994, 8 (01) :1-9
[3]  
GOLBERG DP, 1979, PSYCHOL MED, V9, P139
[4]   GENITAL ULCERATION AS A RISK FACTOR FOR HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
GREENBLATT, RM ;
LUKEHART, SA ;
PLUMMER, FA ;
QUINN, TC ;
CRITCHLOW, CW ;
ASHLEY, RL ;
DCOSTA, LJ ;
NDINYAACHOLA, JO ;
COREY, L ;
RONALD, AR ;
HOLMES, KK .
AIDS, 1988, 2 (01) :47-50
[5]   IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASES ON HIV-INFECTION IN RURAL TANZANIA - RANDOMIZED CONTROLLED TRIAL [J].
GROSSKURTH, H ;
MOSHA, F ;
TODD, J ;
MWIJARUBI, E ;
KLOKKE, A ;
SENKORO, K ;
MAYAUD, P ;
CHANGALUCHA, J ;
NICOLL, A ;
KAGINA, G ;
NEWELL, J ;
MUGEYE, K ;
MABEY, D ;
HAYES, R .
LANCET, 1995, 346 (8974) :530-536
[6]   VIRICIDAL EFFECT OF LACTOBACILLUS-ACIDOPHILUS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - POSSIBLE ROLE IN HETEROSEXUAL TRANSMISSION [J].
KLEBANOFF, SJ ;
COOMBS, RW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :289-292
[7]  
MCCLURE M O, 1991, Antiviral Chemistry and Chemotherapy, V2, P149
[8]   INVESTIGATIONS INTO THE MECHANISM BY WHICH SULFATED POLYSACCHARIDES INHIBIT HIV-INFECTION INVITRO [J].
MCCLURE, MO ;
MOORE, JP ;
BLANC, DF ;
SCOTTING, P ;
COOK, GMW ;
KEYNES, RJ ;
WEBER, JN ;
DAVIES, D ;
WEISS, RA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (01) :19-26
[9]   INFLUENCE OF HOST-CELL TYPE AND V3 LOOP OF THE SURFACE GLYCOPROTEIN ON SUSCEPTIBILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO POLYANION COMPOUNDS [J].
MEYLAN, PRA ;
KORNBLUTH, RS ;
ZBINDEN, I ;
RICHMAN, DD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2910-2916
[10]   THE EFFECTS OF FREQUENT NONOXYNOL-9 USE ON THE VAGINAL AND CERVICAL MUCOSA [J].
NIRUTHISARD, S ;
RODDY, RE ;
CHUTIVONGSE, S .
SEXUALLY TRANSMITTED DISEASES, 1991, 18 (03) :176-179